These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32780510)

  • 21. Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophrenia.
    Zugno AI; Pacheco FD; Budni J; de Oliveira MB; Canever L; Heylmann AS; Wessler PG; da Rosa Silveira F; Mastella GA; Gonçalves CL; Freitas KV; de Castro AA; Streck EL; Quevedo J
    Metab Brain Dis; 2015 Aug; 30(4):1043-53. PubMed ID: 25920483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nardostachys jatamansi Targets BDNF-TrkB to Alleviate Ketamine-Induced Schizophrenia-Like Symptoms in Rats.
    Janardhanan A; Sadanand A; Vanisree AJ
    Neuropsychobiology; 2016; 74(2):104-114. PubMed ID: 28241130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.
    Hou Y; Zhang H; Xie G; Cao X; Zhao Y; Liu Y; Mao Z; Yang J; Wu C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():107-16. PubMed ID: 23603358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pregabalin on behavioral alterations induced by ketamine in rats.
    Nunes EA; Canever L; Oliveira Ld; Luca RD; Quevedo J; Zugno A; Peregrino A; Crippa JA; Dursun SM; Baker GB; Hallak JE
    Braz J Psychiatry; 2012 Oct; 34(3):329-33. PubMed ID: 23429779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prepubertal chronic stress and ketamine administration to rats as a neurodevelopmental model of schizophrenia symptomatology.
    Ram E; Raphaeli S; Avital A
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2307-14. PubMed ID: 23915719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of maternal deprivation on acetylcholinesterase activity and behavioral changes on the ketamine-induced animal model of schizophrenia.
    Zugno AI; de Miranda IM; Budni J; Volpato AM; Luca RD; Deroza PF; de Oliveira MB; Heylmann AS; da Rosa Silveira F; Wessler P; Antunes Mastella G; Cipriano AL; Quevedo J
    Neuroscience; 2013 Sep; 248():252-60. PubMed ID: 23769892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.
    Ben-Azu B; Aderibigbe AO; Eneni AO; Ajayi AM; Umukoro S; Iwalewa EO
    Neurochem Res; 2018 Sep; 43(9):1745-1755. PubMed ID: 29956036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketamine's schizophrenia-like effects are prevented by targeting PTP1B.
    Qin Z; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    Neurobiol Dis; 2021 Jul; 155():105397. PubMed ID: 34015491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms involved in the prevention and reversal of ketamine-induced schizophrenia-like behavior by rutin: the role of glutamic acid decarboxylase isoform-67, cholinergic, Nox-2-oxidative stress pathways in mice.
    Oshodi TO; Ben-Azu B; Ishola IO; Ajayi AM; Emokpae O; Umukoro S
    Mol Biol Rep; 2021 Mar; 48(3):2335-2350. PubMed ID: 33811574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probable mechanisms involved in the antipsychotic-like activity of morin in mice.
    Ben-Azu B; Aderibigbe AO; Omogbiya IA; Ajayi AM; Owoeye O; Olonode ET; Iwalewa EO
    Biomed Pharmacother; 2018 Sep; 105():1079-1090. PubMed ID: 30021344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schizophrenia-like behavior is not altered by melatonin supplementation in rodents.
    Afonso AC; Pacheco FD; Canever L; Wessler PG; Mastella GA; Godoi AK; Hubbe I; Bischoff LM; Bialecki AVS; Zugno AI
    An Acad Bras Cienc; 2020; 92(4):e20190981. PubMed ID: 32844989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of anesthesia on lipopolysaccharide-induced changes in serum cytokines.
    Adams SD; Radhakrishnan RS; Helmer KS; Mercer DW
    J Trauma; 2008 Jul; 65(1):170-4. PubMed ID: 18580536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Forced Swimming Immobility a Good Endpoint for Modeling Negative Symptoms of Schizophrenia? - Study of Sub-Anesthetic Ketamine Repeated Administration Effects.
    Neves G; Borsoi M; Antonio CB; Pranke MA; Betti AH; Rates SMK
    An Acad Bras Cienc; 2017; 89(3):1655-1669. PubMed ID: 28832723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mangiferin ameliorates 6-hydroxydopamine-induced cytotoxicity and oxidative stress in ketamine model of schizophrenia.
    Rao VS; Carvalho AC; Trevisan MT; Andrade GM; Nobre-Júnior HV; Moraes MO; Magalhães HI; Morais TC; Santos FA
    Pharmacol Rep; 2012; 64(4):848-56. PubMed ID: 23087136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways.
    Monte AS; de Souza GC; McIntyre RS; Soczynska JK; dos Santos JV; Cordeiro RC; Ribeiro BM; de Lucena DF; Vasconcelos SM; de Sousa FC; Carvalho AF; Macêdo DS
    J Psychopharmacol; 2013 Nov; 27(11):1032-43. PubMed ID: 24045882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal immune activation leads to age-related behavioral and immunological changes in male rat offspring - the effect of antipsychotic drugs.
    Basta-Kaim A; Szczęsny E; Leśkiewicz M; Głombik K; Slusarczyk J; Budziszewska B; Regulska M; Kubera M; Nowak W; Wędzony K; Lasoń W
    Pharmacol Rep; 2012; 64(6):1400-10. PubMed ID: 23406750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt/GSK-3β and Wnt/β-catenin signaling pathways.
    George MY; Menze ET; Esmat A; Tadros MG; El-Demerdash E
    Life Sci; 2020 May; 249():117535. PubMed ID: 32151688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CaMKIIα expression in a mouse model of NMDAR hypofunction schizophrenia: Putative roles for IGF-1R and TLR4.
    Ogundele OM; Lee CC
    Brain Res Bull; 2018 Mar; 137():53-70. PubMed ID: 29137928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single coadministration of subeffective doses of ascorbic acid and ketamine reverses the depressive-like behavior induced by chronic unpredictable stress in mice.
    Moretti M; Werle I; da Rosa PB; Neis VB; Platt N; Souza SVS; Rodrigues ALS
    Pharmacol Biochem Behav; 2019 Dec; 187():172800. PubMed ID: 31678791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Average spectral power changes at the hippocampal electroencephalogram in schizophrenia model induced by ketamine.
    Sampaio LRL; Borges LTN; Silva JMF; de Andrade FRO; Barbosa TM; Oliveira TQ; Macedo D; Lima RF; Dantas LP; Patrocinio MCA; do Vale OC; Vasconcelos SMM
    Fundam Clin Pharmacol; 2018 Feb; 32(1):60-68. PubMed ID: 28853229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.